Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia
Clinical trial NCT01853982 · TERMINATED
Trial details
- NCT number
- NCT01853982
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-14
- Primary completion
- 2013-11-20
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.